Hearing loss has been rarely reported in Takayasu's arteritis, presents as sudden sensorineural hearing loss and usually responds well to corticosteroid therapy. Hyperbaric Oxygen Therapy is commonly used as a supplementary treatment to corticosteroids for sudden hearing loss. We present the case of a woman with Takayasu's arteritis who had two episodes of hearing loss involving one ear at a time with a 11-month delay between each episode. During the first episode, the patient was treated with high-dose intramuscular corticosteroids with a temporary improvement of auditory threshold, that deteriorated close to previous level 14 days after cessation of therapy. In the second episode, Hyperbaric Oxygen Therapy was associated to corticosteroids, with a significant, longer term improvement in both ears, including the one that had shown to be unresponsive to previous pharmacologic therapy. Oxygen therapy could have played a role in hearing restoration in this patient, as it could have acted synergically with corticosteroids amplifying their effect.

Recovery from repeated sudden hearing loss in a patient with Takayasu’s arteritis treated with hyperbaric oxygen therapy: the first report in the literature / Ralli, Massimo; Greco, Antonio; Falasca, Vincenzo; Altissimi, Giancarlo; Tombolini, Mario; Turchetta, Rosaria; De Fazio, Sara; DE VINCENTIIS, Marco; Cianfrone, Giancarlo. - In: CASE REPORTS IN OTOLARYNGOLOGY. - ISSN 2090-6773. - ELETTRONICO. - 2017:(2017), pp. 1-6. [10.1155/2017/3281984]

Recovery from repeated sudden hearing loss in a patient with Takayasu’s arteritis treated with hyperbaric oxygen therapy: the first report in the literature

RALLI, MASSIMO
Primo
;
GRECO, Antonio
Secondo
;
FALASCA, VINCENZO;ALTISSIMI, Giancarlo;TOMBOLINI, MARIO;TURCHETTA, Rosaria;De Fazio, Sara;DE VINCENTIIS, Marco
Penultimo
;
CIANFRONE, Giancarlo
Ultimo
2017

Abstract

Hearing loss has been rarely reported in Takayasu's arteritis, presents as sudden sensorineural hearing loss and usually responds well to corticosteroid therapy. Hyperbaric Oxygen Therapy is commonly used as a supplementary treatment to corticosteroids for sudden hearing loss. We present the case of a woman with Takayasu's arteritis who had two episodes of hearing loss involving one ear at a time with a 11-month delay between each episode. During the first episode, the patient was treated with high-dose intramuscular corticosteroids with a temporary improvement of auditory threshold, that deteriorated close to previous level 14 days after cessation of therapy. In the second episode, Hyperbaric Oxygen Therapy was associated to corticosteroids, with a significant, longer term improvement in both ears, including the one that had shown to be unresponsive to previous pharmacologic therapy. Oxygen therapy could have played a role in hearing restoration in this patient, as it could have acted synergically with corticosteroids amplifying their effect.
Takayasu's arteritis; hearing loss; hyperbaric oxygen therapy; corticosteroid therapy
01 Pubblicazione su rivista::01i Case report
Recovery from repeated sudden hearing loss in a patient with Takayasu’s arteritis treated with hyperbaric oxygen therapy: the first report in the literature / Ralli, Massimo; Greco, Antonio; Falasca, Vincenzo; Altissimi, Giancarlo; Tombolini, Mario; Turchetta, Rosaria; De Fazio, Sara; DE VINCENTIIS, Marco; Cianfrone, Giancarlo. - In: CASE REPORTS IN OTOLARYNGOLOGY. - ISSN 2090-6773. - ELETTRONICO. - 2017:(2017), pp. 1-6. [10.1155/2017/3281984]
File allegati a questo prodotto
File Dimensione Formato  
Ralli_Recovery_2017.pdf

accesso aperto

Note: https://www.hindawi.com/journals/criot/2017/3281984/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 3.11 MB
Formato Adobe PDF
3.11 MB Adobe PDF Visualizza/Apri PDF
Ralli_Recovery_2017_postprint.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 4.7 MB
Formato Adobe PDF
4.7 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1002874
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
social impact